Minimal clinically important differences for measures of treatment efficacy in Stevens-Johnson syndrome and toxic epidermal necrolysis.

Kim WB, Worley B, Holmes J, Phillips EJ, Beecker J
J Am Acad Dermatol. 2018 79 (6): 1150-1152

PMID: 29890189 · PMCID: PMC6234072 · DOI:10.1016/j.jaad.2018.06.002

MeSH Terms (14)

Clinical Trials as Topic Dermatologists Disease Progression Humans Length of Stay Minimal Clinically Important Difference Professional Practice Re-Epithelialization Research Design Stevens-Johnson Syndrome Surgeons Surveys and Questionnaires Survival Rate Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: